ShockWave Medical (Nasdaq: SWAV), the innovative pioneer of intravascular lithotripsy, has received an all-cash acquisition offer from Johnson & Johnson (NYSE: JNJ) for $335 per share. In today's episode, 7investing advisors Luke Hallard and Simon Erickson discuss why we made ShockWave a 7investing recommendation, several financial details of the offer, and what investors should expect going forward.
---
Send in a voice message: https://podcasters.spotify.com/pod/show/7investing/message
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More